<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="17459">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02879604</url>
  </required_header>
  <id_info>
    <org_study_id>UF 9679</org_study_id>
    <nct_id>NCT02879604</nct_id>
  </id_info>
  <brief_title>Cost-utility Study of a Group of Compensatory Cognitive Remediation in Schizophrenia</brief_title>
  <acronym>Grecco</acronym>
  <official_title>Cost-utility Study of a Group of Compensatory Cognitive Remediation in Schizophrenia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Montpellier</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Assistances publiques hopitaux de Marseille</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospital, Clermont-Ferrand</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Assistances publiques hopitaux de Paris</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hôpital Louis Mourier, Colombes</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hôpital Charles Perrens, Bordeaux</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>CHRU Strasbourg</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Centre hospitalier Alpes Isère, Grenoble</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Centre Hospitalier le Vinatier, Bron</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Laboratoire Santé Publique - Faculté de Médecine - Marseille</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Fondation FondaMental</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Montpellier</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Significant cognitive impairment (executive functions, memory, attention) is common in
      schizophrenia affecting up to 80% of patients. But pharmacological treatments (typical and
      atypical antipsychotic) do not have impact on cognitive functioning. For over 20 years,
      alternative non-pharmacological therapeutics have been developed in schizophrenia. These
      techniques called cognitive remediation specifically target cognitive deficits. The first
      cognitive remediation available for patients was designed to stimulate new learning, or
      relearning, of cognitive tasks, and thus to improve certain deficient domains. These
      procedures were efficient in improving cognition as measured by neurocognitive tests but
      their impact on functioning and daily life was weak. In a second time, compensatory
      remediation has been developed. Compensatory approaches seek to make improvements in the
      patient's functioning by avoiding areas of impairment and recruiting other intact cognitive
      domains or by creating a supportive external environment. In recent meta-analysis
      compensatory remediation has larger effect-size than classical cognitive remediation, with
      an impact on patients psychosocial functioning. Recently, Dr E. Twamley (University of
      California) developed and tested a group-based, manualized, compensatory cognitive training
      intervention.

      Compensatory cognitive training (CCT) is a low-tech, brief intervention and is easily
      transposable in community care. Our team translated this method into French. The
      investigators planned a cost -utility study between CCT and treatment as usual in
      schizophrenia patients with less than 10 years of evolution.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>September 2016</start_date>
  <completion_date type="Anticipated">September 2020</completion_date>
  <primary_completion_date type="Anticipated">September 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Open Label</masking>
  </study_design_info>
  <primary_outcome>
    <measure>cost-utility questionnaire</measure>
    <time_frame>12 months</time_frame>
    <description>cost difference between the 2 group of patients</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Functioning questionnaire</measure>
    <time_frame>3 months</time_frame>
    <description>FROGS, Functional Remission of General Schizophrenia</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">210</enrollment>
  <condition>Schizophrenia</condition>
  <arm_group>
    <arm_group_label>Compensatory cognitive training</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Compensatory cognitive training</description>
  </arm_group>
  <arm_group>
    <arm_group_label>usual treatment</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>usual treatment for shizophrenai</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Compensatory cognitive training</intervention_name>
    <arm_group_label>Compensatory cognitive training</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Usual</intervention_name>
    <arm_group_label>usual treatment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  diagnostic with schizophrénie

          -  less than 10 years of the evolution of the disease

        Exclusion Criteria:
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Delphine Capdevielle, MD-PhD</last_name>
    <phone>033467339727</phone>
    <email>d-capdevielle@chu-montpellier.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Stéphane Raffard, PhD</last_name>
    <phone>033467339702</phone>
    <email>s-raffard@chu-montpellier.fr</email>
  </overall_contact_backup>
  <verification_date>August 2016</verification_date>
  <lastchanged_date>August 22, 2016</lastchanged_date>
  <firstreceived_date>August 17, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Schizophrenia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
